简要回顾从COVID-19中学到的关于药物发现和研究的教训
Subodh Kumar1, Hansraj Kumar1, Joonmoni Lahon2
1Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, India.
Medicine and pharmacy reports
|September 5, 2024
概括
COVID-19大流行加速了抗病毒药物发现和临床试验适应. 经验教训强调全球合作,数据共享和个性化医疗,为未来的传染病准备做好准备.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
背景情况:
- "COVID-19"大流行突出了药物发现和开发的关键方面.
- 关于识别和批准新疗法的过程,我们吸取了重要的教训.
研究的目的:
- 在COVID-19大流行期间审查药物发现和研究进展.
- 确定传染病研究的关键成果和未来方向.
主要方法:
- 关于COVID-19药物发现和开发的文献综述.
- 分析抗病毒药物发现,药物重新定位和临床试验适应方面的进展.
- 检查局限性,包括全球合作和数据共享.
主要成果:
- 在抗病毒药物发现,药物重新定位和临床试验法规方面取得了进展.
- 确定的局限性包括需要加强全球合作,数据透明度和公平分配.
- 讨论了为现有药物寻找新适应症的好处和局限性.
结论:
- 疫情强调了强大的临床试验,药理动力学/药理动力学建模和组合治疗的重要性.
- 未来的方向包括准备,跨学科方法,多样性和针对传染病的个性化医疗.
相关概念视频
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Structure-Activity Relationships and Drug Design
679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drug Administration and Therapy Phases: Overview
418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K


